Contractibility sensor signal evolution predicts cardiovascular events in patients with cardiac resynchronization therapy

Ponikowski, 2016, Eur J Heart Fail, 18, 891, 10.1002/ejhf.592 Plicchi, 2002, PEA I and PEA II based implantable haemodynamic monitor: pre-clinical studies in sheep, Europace, 4, 49, 10.1053/eupc.2001.0204 Brugada, 2017, Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial, Eur Heart J, 38, 730 Sacchi, 2017, Impact of haemodynamic SonR sensor on monitoring of left ventricular function in patients undergoing cardiac resynchronization therapy, Europace, 19, 1695, 10.1093/europace/euw318 Foley, 2011, Left ventricular reverse remodelling, long-term clinical outcome, and mode of death after cardiac resynchronization therapy, Eur J Heart Fail, 13, 43, 10.1093/eurjhf/hfq182 Austin, 2016, Introduction to the analysis of survival data in the presence of competing risks, Circulation, 133, 601, 10.1161/CIRCULATIONAHA.115.017719 Yu, 2002, Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure, Circulation, 105, 438, 10.1161/hc0402.102623 Sutton, 2007, Reverse remodelling in heart failure with cardiac resynchronisation therapy, Heart, 93, 167, 10.1136/hrt.2005.067967 McGowan, 2003, Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods, Am Heart J, 146, 388, 10.1016/S0002-8703(03)00248-5 Bordachar, 2011, Contributions of a hemodynamic sensor embedded in an atrial lead in a porcine model, J Cardiovasc Electrophysiol, 22, 579, 10.1111/j.1540-8167.2010.01930.x Bilchick, 2010, Bundle branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients, Circulation, 122, 2022, 10.1161/CIRCULATIONAHA.110.956011 Hsu, 2012, Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study, J Am Coll Cardiol, 59, 2366, 10.1016/j.jacc.2012.01.065 Varma, 2009, Left ventricular conduction delays and relation to QRS configuration in patients with left ventricular dysfunction, Am J Cardiol, 103, 1578, 10.1016/j.amjcard.2009.01.379 Daly, 2016, The effect of chronic kidney disease on mortality with cardiac resynchronization therapy, Pacing Clin Electrophysiol, 39, 863, 10.1111/pace.12883 Lin, 2011, Renal function and mortality following cardiac resynchronization therapy, Eur Heart J, 32, 184, 10.1093/eurheartj/ehq403 Mansourati, 2014, Heart failure monitoring with a cardiac resynchronization therapy device-based cardiac contractility sensor: a case series, J Med Case Rep, 8, 27, 10.1186/1752-1947-8-27 Gustafsson, 2017, Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes, Eur J Heart Fail, 19, 595, 10.1002/ejhf.779 Goldenberg, 2014, Survival with cardiac resynchronization therapy in mild heart failure, N Engl J Med, 370, 1694, 10.1056/NEJMoa1401426 Higgins, 2003, Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias, J Am Coll Cardiol, 42, 1454, 10.1016/S0735-1097(03)01042-8 Providencia, 2015, Prediction of nonarrhythmic mortality in primary prevention implantable cardioverter-defibrillator patients with ischemic and nonischemic cardiomyopathy, JACC Clin Electrophysiol, 1, 29, 10.1016/j.jacep.2015.01.004